vs
Side-by-side financial comparison of Strive, Inc. (ASST) and SenesTech, Inc. (SNES). Click either name above to swap in a different company.
SenesTech, Inc. is the larger business by last-quarter revenue ($421.0K vs $255.0K, roughly 1.7× Strive, Inc.). SenesTech, Inc. runs the higher net margin — -428.5% vs -75406.7%, a 74978.2% gap on every dollar of revenue. On growth, SenesTech, Inc. posted the faster year-over-year revenue change (-16.0% vs -74.1%). Over the past eight quarters, Strive, Inc.'s revenue compounded faster (77.6% CAGR vs 0.7%).
Strive Asset Management is an American investment management firm founded in 2022. The firm operates mutual funds, exchange-traded products (ETPs), and wealth management services. Headquartered in Columbus, Ohio, it operates as a subsidiary of Strive Enterprises, Inc. and is registered with the U.S. Securities and Exchange Commission (SEC) as an investment adviser.
SenesTech, Inc. is an agricultural biotechnology life-sciences company, specializing in fertility management as a form of pest control. The company's primary product, ContraPest is designed to make brown and black rats infertile. SenesTech is headquartered in Phoenix, Arizona.
ASST vs SNES — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $255.0K | $421.0K |
| Net Profit | $-192.3M | $-1.8M |
| Gross Margin | — | 55.3% |
| Operating Margin | -17288.6% | -446.8% |
| Net Margin | -75406.7% | -428.5% |
| Revenue YoY | -74.1% | -16.0% |
| Net Profit YoY | -2726.9% | -43.7% |
| EPS (diluted) | $-0.22 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $421.0K | ||
| Q3 25 | $255.0K | $690.0K | ||
| Q2 25 | $173.3K | $625.0K | ||
| Q1 25 | $170.7K | $485.0K | ||
| Q4 24 | $212.8K | $501.0K | ||
| Q3 24 | $984.0K | $482.0K | ||
| Q2 24 | $93.0K | $459.0K | ||
| Q1 24 | $124.8K | $415.0K |
| Q4 25 | — | $-1.8M | ||
| Q3 25 | $-192.3M | $-1.3M | ||
| Q2 25 | $-8.9M | $-1.6M | ||
| Q1 25 | $-3.7M | $-1.7M | ||
| Q4 24 | $-4.1M | $-1.3M | ||
| Q3 24 | $-6.8M | $-1.5M | ||
| Q2 24 | $-5.9M | $-1.6M | ||
| Q1 24 | $-4.8M | $-1.8M |
| Q4 25 | — | 55.3% | ||
| Q3 25 | — | 62.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 64.5% | ||
| Q4 24 | — | 60.9% | ||
| Q3 24 | — | 65.4% | ||
| Q2 24 | — | 54.2% | ||
| Q1 24 | — | 32.5% |
| Q4 25 | — | -446.8% | ||
| Q3 25 | -17288.6% | -195.2% | ||
| Q2 25 | -1553.9% | -258.2% | ||
| Q1 25 | -970.5% | -342.9% | ||
| Q4 24 | -5889.5% | -250.9% | ||
| Q3 24 | -712.4% | -321.0% | ||
| Q2 24 | -1857.2% | -349.0% | ||
| Q1 24 | -1110.9% | -444.1% |
| Q4 25 | — | -428.5% | ||
| Q3 25 | -75406.7% | -188.1% | ||
| Q2 25 | -5122.4% | -258.6% | ||
| Q1 25 | -2195.6% | -343.3% | ||
| Q4 24 | -1935.5% | -250.5% | ||
| Q3 24 | -691.3% | -313.9% | ||
| Q2 24 | -6313.1% | -345.1% | ||
| Q1 24 | -3837.7% | -441.4% |
| Q4 25 | — | $0.48 | ||
| Q3 25 | $-0.22 | $-0.28 | ||
| Q2 25 | $-0.17 | $-0.87 | ||
| Q1 25 | $-0.13 | $-1.28 | ||
| Q4 24 | $-5.62 | $-0.15 | ||
| Q3 24 | $-3.06 | $-2.07 | ||
| Q2 24 | $-0.58 | $-3.08 | ||
| Q1 24 | $-0.49 | $-3.56 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $109.1M | $8.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.4M | $9.6M |
| Total Assets | $792.6M | $12.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.6M | ||
| Q3 25 | $109.1M | $10.2M | ||
| Q2 25 | $2.5M | $6.1M | ||
| Q1 25 | $4.2M | $1.7M | ||
| Q4 24 | $6.2M | $1.3M | ||
| Q3 24 | $2.1M | $2.5M | ||
| Q2 24 | $1.9M | $2.0M | ||
| Q1 24 | $1.9M | $3.6M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | $779.4M | $11.3M | ||
| Q2 25 | $10.7M | $7.0M | ||
| Q1 25 | $19.6M | $2.9M | ||
| Q4 24 | $23.3M | $2.5M | ||
| Q3 24 | $27.5M | $3.7M | ||
| Q2 24 | $5.4M | $3.1M | ||
| Q1 24 | $11.3M | $4.6M |
| Q4 25 | — | $12.8M | ||
| Q3 25 | $792.6M | $14.6M | ||
| Q2 25 | $3.3M | $10.4M | ||
| Q1 25 | $5.0M | $3.6M | ||
| Q4 24 | $28.2M | $3.3M | ||
| Q3 24 | $2.6M | $4.4M | ||
| Q2 24 | $2.4M | $4.0M | ||
| Q1 24 | $2.1M | $5.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-14.0M | $-1.7M |
| Free Cash FlowOCF − Capex | — | $-1.7M |
| FCF MarginFCF / Revenue | — | -398.3% |
| Capex IntensityCapex / Revenue | 0.0% | 3.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-5.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-1.7M | ||
| Q3 25 | $-14.0M | $-1.4M | ||
| Q2 25 | $-1.7M | $-1.1M | ||
| Q1 25 | $-1.6M | $-1.6M | ||
| Q4 24 | $-21.6M | $-1.2M | ||
| Q3 24 | $-13.2M | $-1.4M | ||
| Q2 24 | $-1.3M | $-1.6M | ||
| Q1 24 | $-1.0M | $-1.8M |
| Q4 25 | — | $-1.7M | ||
| Q3 25 | — | $-1.4M | ||
| Q2 25 | — | $-1.2M | ||
| Q1 25 | — | $-1.6M | ||
| Q4 24 | $-21.6M | $-1.2M | ||
| Q3 24 | $-13.4M | $-1.4M | ||
| Q2 24 | $-1.3M | $-1.6M | ||
| Q1 24 | $-1.1M | $-1.8M |
| Q4 25 | — | -398.3% | ||
| Q3 25 | — | -205.9% | ||
| Q2 25 | — | -191.5% | ||
| Q1 25 | — | -328.5% | ||
| Q4 24 | -10161.2% | -246.1% | ||
| Q3 24 | -1360.3% | -296.1% | ||
| Q2 24 | -1379.4% | -354.2% | ||
| Q1 24 | -844.7% | -441.2% |
| Q4 25 | — | 3.1% | ||
| Q3 25 | 0.0% | 6.1% | ||
| Q2 25 | — | 7.5% | ||
| Q1 25 | — | 7.4% | ||
| Q4 24 | 11.3% | 3.0% | ||
| Q3 24 | 18.8% | 5.8% | ||
| Q2 24 | 3.1% | 8.5% | ||
| Q1 24 | 9.5% | 0.5% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
